Biologics | News | 0 Comment | 22 Oct, 2024
Moleac is excited to announce a significant milestone in the journey of NeuroAiD II MLC901, as PT Ferron Par Pharmaceuti...Read more
Biologics | News | 0 Comment | 17 Oct, 2024
Univercells Technologies by Donaldson, a global leader in bioprocessing technologies, proudly announces the launch of it...Read more
Biologics | News | By Ankit Kankar | ankit.kankar@mmactiv.com | 0 Comment | 01 Sep, 2024
Antibody Engineering & Therapeutics Asia: Date: October 21 – 23, 2024Location: The Westin Miyako Kyoto Antib...Read more
Eppendorf Launches BioNsight Cloud for Enhanced Bioprocess Monitoring and Analysis
Biologics | News | 0 Comment | 31 Jul, 2024
Data is the key to bioprocess development today. It is needed to understand which critical process parameters infl...Read more
Pierre-Alain Ruffieux Joins Cytiva as COO, Sets Sights on Asia Pacific Growth
Biologics | Opinion | By Ankit Kankar | ankit.kankar@mmactiv.com | 0 Comment | 04 Jul, 2024
On July 1, 2024, Cytiva significantly bolstered its leadership team by appointing Pierre-Alain Ruffieux as Chief...Read more
Biologics | News | 0 Comment | 12 Apr, 2024
Serum Institute of India (SII), the world’s largest vaccine manufacturer, has joined forces with Univercells,...Read more
Biocon Biologics partners with Sandoz Australia for cancer biosimilars
Biologics | News | 0 Comment | 09 Feb, 2024
Indian firm Biocon Biologics Ltd (BBL), a fully integrated biosimilars company and subsidiary of Biocon, has announ...Read more
MarkHerz and Polyplus Collaborate to Advance Cell and Gene Therapy Process Standards and Lower Costs
Biologics | News | 0 Comment | 19 Dec, 2023
The teams will work to improve process efficiency leveraging Polyplus products and expertise with MarkHerz man...Read more
Problem-solving in upstream bioprocessing
Biologics | News | 0 Comment | 22 Aug, 2023
The field of cell and gene therapies is a new and emerging category of seeking methods to cure diseases by restoring or ...Read more
Israel's MediWound announces launch of biologic drug NexoBrid in Japan
Biologics | News | 0 Comment | 02 Aug, 2023
Israel-based biopharma firm MediWound has announced that its strategic partner, Kaken Pharmaceutical has launched NexoBr...Read more
US-based Rani Therapeutics expands biologics partnership with Korean firm Celltrion
Biologics | News | 0 Comment | 08 Jun, 2023
Rani Therapeutics Holdings, a clinical-stage biotherapeutics company focused on the oral delivery of biologics and drugs...Read more
Biologics | News | 0 Comment | 23 May, 2023
Current prenatal diagnostic methods are highly invasive, carrying risk of miscarriage, infection, and injury to the foet...Read more
LogiPharma to launch life sciences supply chain conference summit in Singapore (June 2023)
Biologics | Company results | 1 Comment | 28 Mar, 2023
LogiPharma, the global life sciences supply chain conference brand will be holding its inaugural Asian summit from June ...Read more
Register Now :10x Genomics to host APAC Spatial Biology Symposium on November 22
Biologics | News | 0 Comment | 01 Nov, 2022
The future of spatial is here. Join us: https://10xgen.com/3fn3FZw Advances in spatial technologi...Read more
Biocon out-licenses two biosimilar assets for commercialization in Japan
Biologics | News | 0 Comment | 17 Oct, 2022
Indian firm Biocon Biologics has entered into a strategic out-licensing agreement with Japanese pharmaceuticals com...Read more
Pall Corporation Launches Three New Allegro™ Connect Systems
Biologics | News | 0 Comment | 27 Sep, 2022
Pall Corporation extends its bioprocessing solution portfolio with the launch of three new Allegro Connect Systems. In c...Read more
Thermo Fisher invests $160 M to expand bioproduction capacity in Greater Boston
Biologics | News | 0 Comment | 20 Sep, 2022
Thermo Fisher Scientific Inc., the world leader in serving science, has opened a new biomanufacturing facility in Chelms...Read more
Biologics | News | 0 Comment | 08 Sep, 2022
The new in vivo-jetRNA®+ transfection reagent an efficient, stable, and safe delivery system leading to 100% mR...Read more